facebook

Linked Care With Ocular Oncology: Fast Referral and Follow-Up if Melanoma Is Suspected

1 min read

When ocular melanoma is suspected, speed and coordination matter because management decisions are time-sensitive and depend on subspecialist imaging interpretation and treatment planning. ²

Modern ocular oncology pathways aim to achieve:

  • Rapid diagnostic confirmation
  • Appropriate local treatment (for example plaque radiotherapy where indicated) ¹
  • Long-term systemic surveillance and shared follow-up

Treatment selection depends on tumour size, location, and risk profile. Plaque radiotherapy has strong evidence for tumour control in many settings, including challenging locations, while preserving the eye in a large proportion of patients. ¹ Because metastasis risk is related to tumour biology and stage, structured follow-up remains important even after local control is achieved. ³

A “linked care” model reduces delay and duplication: local imaging and symptom triage, fast oncology escalation when thresholds are crossed, then shared monitoring once the diagnosis and plan are established. ²

References

  1. Sagoo MS, Shields CL, Kaliki S, Shields JA. Plaque radiotherapy for juxtapapillary choroidal melanoma: tumor control and visual outcomes in 650 consecutive cases. Archives of Ophthalmology. 2012;130(3):264-271. doi:10.1001/archophthalmol.2011.1730. PMID: 22411697.
  2. Shields CL, Demirci H, Materin MA, Marr BP, Mashayekhi A, Shields JA. Clinical factors in the identification of small choroidal melanoma. Canadian Journal of Ophthalmology. 2004;39(4):351-357. doi:10.1016/S0008-4182(04)80005-X. PMID: 15327099.
  3. Shields CL, Shields JA. Melanoma of the eye: revealing hidden secrets, one at a time. Clinical and Experimental Ophthalmology. 2015;43(8):734-749. doi:10.1111/ceo.12547. PMID: 26213399.

Related Topics

About Blue Fin Vision®

Blue Fin Vision® is a GMC-registered, consultant-led ophthalmology clinic with CQC-regulated facilities across London, Hertfordshire, and Essex. Patient outcomes are independently audited by the National Ophthalmology Database, confirming exceptionally low complication rates.